Guselkumab offers the flexibility of self-administration from the start of treatment in both ulcerative colitis (UC) and Crohn’s disease (CD),1,2,3 providing the simplicity of a fully subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback